Composition
Vildagliptin 50 mg & Metformin Hydrochloride 1000 mg Tablets I.P.
Description
VIDLARV-M 1000 (Vildagliptin 50 mg & Metformin Hydrochloride 1000 mg Tablets I.P.) is a combination antidiabetic medicine used for the management of Type 2 diabetes mellitus. It combines Vildagliptin, a DPP-4 inhibitor that enhances insulin secretion, with Metformin, which helps reduce glucose production in the liver and improves insulin sensitivity. Together, they provide effective blood glucose control when diet and exercise alone are not sufficient. Manufactured under stringent quality standards, Arvantis Pharmaceuticals ensures safe, effective, and reliable tablets with consistent therapeutic performance. These tablets are ideal for PCD Pharma Franchise, third-party manufacturing, hospital supply, institutional procurement, and bulk distribution across Delhi and India.
Enter your details to start WhatsApp chat